TGTX
TGTX
NASDAQ · Biotechnology

Tg Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$49.76
+0.21 (+0.42%)
As of Aug 8, 1:25 AM ET ·
TGTX News1 articles
TG Therapeutics Stock Drops 9.8% Despite Strong BRIUMVI Sales as Costs Surge
TG Therapeutics shares fell 9.8% as Q2 revenue rose 70% but operating income declined 38% on surging costs. Guidance raised modestly.
Earnings